Withania somnifera (L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy

Withania somnifera (L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy

Coronavirus disease 2019 (COVID-19) pandemic has killed huge populations throughout the world and acts as a high-risk factor for elderly and young immune-suppressed patients. There is a critical need to build up secure, reliable, and efficient drugs against to the infection of severe acute respirato...

Full description

Bibliographic Details
Main Authors: Manali Singh, Kuldeep Jayant, Dipti Singh, Shivani Bhutani, Nitesh Kumar Poddar, Anis Ahmad Chaudhary, Salah-Ud-Din Khan, Mohd Adnan, Arif Jamal Siddiqui, Md Imtaiyaz Hassan, Faez Iqbal Khan, Dakun Lai, Shahanavaj Khan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
SARS-CoV-2
ACE2 receptors
Withania somnifera
Ashwagandha
COVID-19
targeted therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.933824/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2022.933824/full

Similar Items